background
meningoencephalomyel
unknown
origin
muo
common
lifethreaten
neuroinflammatori
diseas
dog
featur
diseas
suggest
underli
immunemedi
process
associ
diseas
pathogen
still
unknown
hypothesisobject
search
candid
etiolog
agent
associ
case
muo
use
next
gener
metagenom
sequenc
anim
twentytwo
dog
diagnos
either
muo
csf
brain
noninflammatori
cn
diseas
inconsist
muo
csf
brain
serv
neg
control
method
case
control
studi
perform
identifi
muo
nonmuo
case
sampl
blindli
process
unblind
compar
analys
inclus
criteria
muo
case
includ
consist
mri
lesion
inflammatori
csf
neg
pcr
panel
infecti
agent
histopatholog
diagnosi
dog
glucocorticoid
therapi
within
week
sampl
collect
exclud
freshfrozen
cerebrospin
fluid
csf
brain
sampl
collect
rna
dna
extract
separ
shotgun
metagenom
sequenc
known
posit
sampl
use
control
valid
sequenc
analysi
pipelin
establish
limit
detect
sequenc
result
analyz
nucleotid
protein
level
broad
comparison
known
infecti
organ
result
candid
etiolog
agent
identifi
dog
muo
conclus
clinic
import
result
support
prove
hypothesi
muo
associ
infecti
agent
might
autoimmun
diseas
muo
thought
account
case
inflammatori
cn
diseas
dog
prognosi
untreat
muo
poor
treatment
immunosuppress
drug
corticosteroid
allevi
clinic
sign
delay
progress
diseas
suggest
muo
immunemedi
diseas
howev
studi
target
inflammatori
compon
gme
found
predomin
mhc
class
ii
cell
might
result
delay
hypersensit
reaction
therefor
whether
immun
respons
target
infect
critic
open
question
studi
sought
answer
current
etiolog
muo
remain
unknown
studi
search
infecti
etiolog
fail
reveal
consist
infecti
agent
prior
studi
util
polymeras
chain
reaction
pcr
serolog
cultur
immunohistochemistri
combin
test
investig
virus
commonli
implic
cn
diseas
includ
herpesvirus
adenovirus
parvovirus
canin
parainfluenza
viru
encephalomyocard
viru
bunyavirus
coronavirus
enterovirus
flavivirus
paramyxovirus
parechovirus
although
overwhelm
major
studi
neg
inconclus
limit
target
test
specif
agent
oppos
util
less
bias
methodolog
search
pathogen
limit
impact
understand
human
neurolog
diseas
well
larg
analys
human
enceph
case
target
method
fail
detect
infecti
agent
suspect
case
studi
util
pathogen
discoveri
techniqu
bypass
mani
limit
specif
diagnost
nextgener
metagenom
sequenc
technolog
emerg
human
veterinari
medicin
invalu
tool
pathogen
discoveri
neurolog
diseas
unknown
etiolog
metagenom
sequenc
total
nucleic
acid
clinic
environment
sampl
randomli
sequenc
taxonom
categor
comparison
known
sequenc
public
databas
studi
cerebrospin
fluid
csf
brain
dog
without
muo
sampl
antemortem
postmortem
techniqu
previou
investig
muo
dog
brain
sampl
test
infecti
agent
howev
csf
common
sampl
util
clinic
evalu
neurolog
diseas
detect
infecti
agent
nucleic
acid
especi
pcr
csf
readili
avail
antemortem
sampl
therefor
clinic
relev
antemortem
diagnosi
muo
addit
csf
success
util
previou
metagenom
sequenc
studi
detect
infecti
organ
enceph
therefor
base
sampl
avail
clinic
relev
studi
util
csf
brain
attempt
identifi
candid
etiolog
agent
muo
includ
diseas
group
studi
dog
greater
six
month
age
neurolog
examin
consist
focal
multifoc
neurolog
dysfunct
addit
inclus
criteria
includ
neg
pcr
test
cerebrospin
fluid
whole
blood
infecti
agent
caus
member
speci
genera
toxoplasma
gondii
neospora
caninum
ehrlichia
cani
ehrlichia
ewingii
anaplasma
neorickettsia
bartonella
rickettsia
presenc
multifoc
hyperintens
lesion
mri
csf
pleocytosi
nucleat
cell
count
greater
cellsll
greater
mononuclear
cell
red
blood
cell
count
less
cellsll
case
necropsi
perform
histopatholog
confirm
diseas
accept
absenc
infecti
diseas
test
mri
csf
inflammatori
natur
muo
potenti
subject
glucocorticoid
administ
within
two
week
csf
antemortem
brain
collect
exclud
studi
howev
criteria
use
postmortem
brain
sampl
three
anim
diseas
group
one
anim
control
group
receiv
antimicrobi
within
sever
day
sampl
collect
could
alter
result
infecti
diseas
test
anim
control
nonmuo
group
subject
age
criteria
diseas
group
muo
control
case
low
index
suspicion
inflammatori
diseas
base
noninflammatori
csf
analysi
inconsist
mri
find
histolog
confirm
nonmuo
diseas
process
combin
find
sampl
brain
tissu
obtain
use
asept
surgic
techniqu
sharp
dissect
diseas
group
sampl
taken
region
brain
show
abnorm
mri
area
brain
associ
clinic
sign
mri
avail
ie
multipl
area
cerebellum
sampl
dog
cerebellar
sign
anim
control
group
sampl
taken
cerebr
cortex
portion
tissu
sampl
place
asept
steril
contain
store
remaind
sampl
place
neutral
buffer
formalin
process
use
standard
paraffinembed
histolog
techniqu
microscop
evalu
lm
hematoxylin
eosinstain
tissu
section
brain
sampl
collect
time
necropsi
process
ident
csf
collect
gener
anesthesia
via
cerebellomedullari
cistern
lumbosacr
centesi
use
asept
techniqu
csf
collect
area
surgic
prep
use
chlorhexidin
glucon
scrub
inch
inch
gaug
spinal
needl
use
collect
csf
steril
tube
csf
store
anim
diseas
muo
control
nonmuo
group
receiv
physic
neurolog
examin
muo
group
anim
complet
blood
count
anim
serum
blood
chemistri
csf
analysi
infecti
diseas
test
whole
blood
csf
mri
anim
necropsi
histopatholog
one
anim
also
antemortem
brain
biopsi
collect
anim
inflammatori
group
euthan
die
result
diseas
current
stabl
lost
followup
tabl
control
group
anim
csf
analysi
anim
cbc
serum
blood
chemistri
mri
test
infecti
diseas
whole
blood
csf
anim
necropsi
histopatholog
anim
also
antemortem
brain
biopsi
collect
one
necropsi
anim
control
group
diagnos
inconsist
muo
see
tabl
list
anim
group
euthan
current
stabl
lost
followup
tabl
total
rna
extract
freshfrozen
csf
brain
sampl
dog
cani
familiari
fit
inclus
control
criteria
describ
sampl
blind
case
control
origin
process
addit
rna
extract
postmortem
brain
sampl
mule
deer
odocoileu
hemionu
green
tree
python
morelia
viridi
american
crow
corvu
brachyrhyncho
american
robin
turdu
migratoriu
previous
test
pcr
metagenom
sequenc
found
infect
specif
known
infecti
agent
use
posit
control
rna
extract
use
combin
trizol
tissu
ambion
life
technolog
trizol
ls
bodi
fluid
ambion
life
technolog
rna
clean
concentr
column
zymo
research
approxim
mg
brain
tissu
ad
ml
trizol
bodi
fluid
csf
serum
blood
ad
trizol
ls
incub
room
temperatur
rt
minut
tissu
sampl
macer
use
singl
steril
metal
bb
shaken
tissuelyz
qiagen
hz
minut
chloroform
sigmaaldrich
ad
shaken
second
hand
incub
rt
minut
sampl
spun
rpm
minut
rt
aqueou
phase
remov
approxim
ad
mixtur
rnabind
buffer
zymo
research
ethanol
etoh
ad
rna
clean
concentr
column
zymo
research
interphas
organ
phase
set
asid
dna
extract
see
rna
column
wash
rna
wash
buffer
incub
u
dnase
enzym
neb
dnase
buffer
neb
rna
wash
buffer
minut
column
spun
remov
dnase
mixtur
wash
rna
prep
buffer
addit
wash
rna
wash
buffer
perform
column
dri
minut
highspe
spin
rna
sampl
elut
rnasefre
water
csf
sampl
undetect
concentr
rna
fluorometr
quantif
sampl
along
templat
control
revers
transcrib
second
dna
strand
synthes
total
dna
amplifi
use
ovat
rna
amplif
system
nugen
accord
manufactur
protocol
extract
rna
brain
sampl
approxim
nanogram
rna
ad
pmol
random
hexam
oligonucleotid
nnnnnn
incub
minut
separ
templat
control
also
use
sampl
revers
transcript
reaction
mixtur
contain
superscript
iii
fs
reaction
buffer
invitrogen
mm
dithiothreitol
invitrogen
mm
deoxynucleosid
triphosph
dntp
u
superscript
iii
revers
transcriptas
enzym
invitrogen
ad
rnaoligom
mix
total
reaction
volum
incub
minut
minut
minut
u
rnase
h
neb
dilut
superscript
iii
fs
reaction
buffer
pmol
ad
reaction
mixtur
incub
minut
follow
minut
singlestrand
cdna
convert
doublestrand
dna
ad
u
klenow
dna
polymeras
exoneb
superscript
iii
fs
reaction
buffer
diseas
case
repres
anim
diagnos
muo
base
clinic
present
antemortem
diagnost
without
postmortem
assess
antemortem
diagnosi
could
classifi
muo
subtyp
postmortem
diagnosi
made
case
two
diagnos
either
nme
gme
two
meningoenceph
lesion
specif
subset
muo
see
discuss
control
case
anim
noninflammatori
csf
either
definit
nonmuo
diagnosi
addit
clinic
find
inconsist
muo
diagnost
sampl
use
fraction
specifi
appli
group
muo
meningoencephalomyel
unknown
origin
meningoenceph
nme
necrot
meningoenceph
gme
granulomat
meningoencephalomyel
mm
dntp
incub
minut
dna
purifi
use
seramag
speed
bead
beaddna
volum
ratio
accord
manufactur
protocol
dna
elut
molecular
grade
water
sigmaaldrich
interphas
organ
phase
trizol
extract
describ
use
dna
extract
accord
manufactur
protocol
invitrogen
minor
alter
briefli
etoh
per
ml
trizol
ad
interphas
organ
phase
gentli
mix
incub
minut
rt
sampl
centrifug
minut
rt
supernat
remov
discard
dna
pellet
wash
twice
ml
sodium
citrat
etoh
ph
per
ml
trizol
minut
rt
incub
minut
centrifug
remov
supernat
dna
pellet
resuspend
etoh
gentli
mix
incub
minut
rt
sampl
centrifug
minut
supernat
discard
pellet
airdri
minut
dna
pellet
resuspend
molecular
grade
water
sigmaaldrich
heat
minut
centrifug
minut
supernat
contain
dna
transfer
ml
conic
new
tube
purifi
use
seramag
speed
bead
previous
describ
csf
sampl
amplifi
gener
detect
level
dna
fluorometr
quantif
perform
use
isotherm
strand
displac
amplif
five
templat
includ
templat
control
ad
lm
random
hexam
primer
incub
minut
place
directli
ice
templat
primer
ad
mixtur
contain
buffer
neb
bovin
serum
albumin
neb
mm
dntp
mm
dithiothreitol
invitrogen
u
dna
polymeras
neb
sampl
incub
hour
minut
dna
concentr
sampl
rna
dna
deriv
sampl
measur
fluorometr
ng
use
templat
tagment
dna
buffer
tagment
dna
enzym
illumina
mixtur
incub
minut
place
directli
ice
tagment
dna
clean
seramag
speed
bead
previous
describ
use
templat
addit
fulllength
adaptor
uniqu
barcod
combin
pcr
pcr
reaction
contain
kapa
realtim
librari
amplif
master
mix
kapa
biosystem
lm
primer
respect
lm
adapt
barcod
primer
thermocycl
condit
consecut
order
minut
second
cycl
second
second
minut
rel
concentr
librari
measur
quantit
pcr
qpcr
reaction
contain
homemad
qpcr
master
mix
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
dntp
glycerol
sybr
green
life
technolog
u
taq
polymeras
lm
primer
equival
amount
dna
sampl
pool
clean
use
seramag
speed
bead
previous
describ
pool
librari
run
agaros
gel
size
select
nucleotid
gel
extract
gel
dna
recoveri
kit
zymo
accord
manufactur
protocol
sizeselect
pool
librari
amplifi
pcr
mixtur
contain
kapa
realtim
librari
amplif
mix
pmol
librari
templat
total
reaction
volum
pcr
also
includ
singl
reaction
separ
fluorometr
standard
kapa
thermocycl
condit
second
cycl
second
second
minut
sampl
curv
pass
standard
dna
purifi
use
seramag
speed
bead
previous
describ
librari
quantif
perform
illumina
librari
quantif
kit
kapa
biosystem
accord
manufactur
protocol
sequenc
perform
illumina
nextseq
instrument
nextseq
high
output
kit
cycl
sequenc
trim
use
cutadapt
version
trim
adaptor
sequenc
lowqual
base
remov
trim
sequenc
less
nt
long
qualiti
base
set
default
qualiti
cutoff
set
end
first
base
sequenc
also
trim
cdhitdup
sequenc
cluster
tool
use
collaps
read
global
pairwis
ident
leav
uniqu
read
remain
hostderiv
sequenc
filter
use
align
tool
version
first
bowti
index
gener
host
genom
sequenc
assembl
dog
assembl
green
tree
python
mule
deer
assembl
american
crow
avail
assembl
ncbi
assembl
databas
order
passeriform
robin
hoodedcrowgenom
sequenc
align
local
mode
align
score
greater
remov
spade
genom
assembl
version
use
gener
contigu
sequenc
contig
taxonom
categor
sequenc
ncbi
nt
databas
queri
contig
greater
nt
use
blastn
align
tool
version
hit
expect
valu
less
assign
taxonom
accord
sequenc
highest
align
score
addit
attempt
categor
contig
diverg
produc
high
score
ntnt
align
ncbi
nr
databas
queri
version
minimum
length
amino
acid
expect
valu
process
perform
use
read
form
contigu
sequenc
spade
genom
assembl
except
gsnap
align
tool
version
use
instead
blastn
raw
sequenc
data
deposit
ncbi
short
read
archiv
databas
access
look
taxa
specif
associ
case
control
sampl
unblind
dataset
identifi
either
muo
nonmuo
nm
taxonom
identif
taxid
present
within
muo
sampl
also
present
nm
sampl
remov
analysi
next
remain
taxid
compar
muo
sampl
fraction
gener
taxid
determin
number
muo
sampl
align
specif
taxid
total
number
sampl
evalu
taxid
occur
two
muo
sampl
sequenc
associ
taxid
manual
inspect
queri
use
ncbi
blastn
blastx
corrobor
initi
taxonom
assess
perform
four
time
sampl
use
differ
sequenc
output
spade
gener
contigu
sequenc
queri
blastn
individu
read
queri
gsnap
eleven
case
muo
collect
studi
tabl
seven
case
diagnos
base
inflammatori
csf
collect
prior
immunosuppress
therapi
neg
infecti
diseas
panel
mri
find
four
case
diagnos
meningoenceph
postmortem
histopatholog
two
case
definit
diagnos
subtyp
muo
nme
gme
gme
case
includ
full
diagnost
mri
imageguid
brain
biopsi
postmortem
histopatholog
show
classic
histolog
featur
gme
diagnosi
case
ultim
made
postmortem
microscopi
necropsi
brain
tissu
histopatholog
brain
biopsi
obtain
antemortem
consid
nondiagnost
neither
two
case
receiv
immunosuppress
therapi
prior
postmortem
evalu
brain
two
histolog
examin
case
diagnos
meningoenceph
case
small
number
macrophag
lymphocyt
plasma
cell
within
mening
around
cerebr
blood
vessel
gray
white
matter
well
variabl
region
vacuol
within
neuropil
axon
degener
encephalomalacia
consist
howev
case
exhibit
classic
histolog
pattern
associ
specif
subtyp
muo
contrast
histolog
diagnos
gme
nme
case
anim
receiv
dose
glucocorticoid
either
prednison
dexamethason
chemotherapi
cytarabin
prior
postmortem
evalu
one
six
month
three
day
prior
euthanasia
death
remain
case
control
group
diagnos
diseas
inconsist
muo
includ
neoplast
degen
traumat
idiopath
epilepsi
tabl
serv
neg
control
case
rna
dna
extract
csf
brain
sampl
muo
dog
nonmuo
dog
well
multipl
posit
control
sampl
nucleic
acid
convert
sequenc
librari
sequenc
illumina
nextseq
instrument
dataset
contain
averag
sequenc
per
sampl
stepwis
data
analysi
pipelin
use
remov
adaptor
sequenc
lowqual
read
collaps
sequenc
uniqu
read
filter
dogderiv
sequenc
approxim
sequenc
remain
sampl
filter
tabl
remain
sequenc
assembl
longer
contigu
sequenc
contig
queri
databas
nucleotid
protein
sequenc
identifi
possibl
pathogenderiv
sequenc
sequenc
singl
organ
found
muo
sampl
organ
inconsist
dna
rna
tissu
well
brain
csf
collect
anim
major
sequenc
lack
specif
singl
organ
base
nucleotid
protein
sequenc
analysi
either
poor
qualiti
read
sequenc
low
complex
highli
conserv
thu
taxonom
ambigu
case
eukaryot
organ
detect
number
bacterialalign
read
also
detect
howev
rang
bacteri
speci
inconsist
given
organ
among
sampl
deem
environment
contamin
common
bacteria
detect
pseudomona
streptococcu
staphylococcu
speci
low
number
viral
speci
detect
present
sole
within
muo
sampl
bacteriophag
therefor
unlik
associ
diseas
overal
consist
specif
candid
etiolog
candid
detect
sequenc
analyz
parallel
number
known
posit
sampl
valid
approach
establish
limit
detect
includ
brain
captiv
green
tree
python
posit
python
nidoviru
brain
wild
mule
deer
posit
caprin
herpesviru
brain
wildcaught
american
robin
experiment
infect
west
nile
viru
wnv
brain
wildcaught
american
crow
experiment
infect
wnv
sampl
previous
test
posit
metagenom
green
tree
python
mule
deer
target
nextgener
sequenc
crow
robin
use
ident
analysi
pipelin
posit
control
sampl
except
use
differ
appropri
genom
assembl
filter
host
sequenc
expect
detect
python
nidoviru
caprin
herpesviru
wnv
green
tree
python
mule
deer
crow
respect
use
metagenom
sequenc
approach
tabl
detect
wnv
experiment
infect
robin
brain
confirm
sampl
posit
wnv
rna
qrtpcr
quantifi
wnv
copi
number
bird
brain
sampl
genom
copiesl
rna
robin
genom
copiesl
rna
crow
muo
idiopath
inflammatori
neurolog
diseas
includ
gme
necrot
encephalitid
nme
nle
pathogen
mechan
underli
muo
remain
unknown
similar
previou
target
diagnost
studi
studi
use
less
bias
approach
fail
detect
infecti
agent
consist
associ
canin
muo
case
sever
possibl
biolog
technic
explan
studi
inabl
identifi
candid
etiolog
agent
muo
includ
underli
pathogenesi
diseas
sampl
type
collect
method
case
inclus
criteria
sensit
diagnost
databas
limit
first
possibl
inflamm
observ
muo
infecti
etiolog
second
might
muo
infecti
caus
sampl
point
natur
histori
diseas
initi
pathogen
longer
present
detect
amount
possibl
could
investig
develop
comprehens
serolog
panel
known
canin
pathogen
would
enabl
retrospect
sampl
dog
without
muo
third
cn
lesion
could
secondari
primari
infect
elsewher
bodi
result
system
respons
manifest
meningoenceph
lesion
could
disproport
respons
lowlevel
cn
infect
evalu
multipl
tissu
type
dog
diagnos
muo
beyond
cn
sampl
could
help
assess
possibl
fourth
might
sampl
wrong
region
cn
muo
like
mani
neurolog
diseas
focal
multifoc
distribut
limit
like
appli
biopsypostmortem
sampl
pathogen
detect
csf
howev
low
inconsist
shed
organ
csf
could
reduc
likelihood
detect
futur
studi
could
benefit
consist
use
antemortem
imageguid
biopsi
muo
case
sampl
multipl
section
cn
postmortem
muo
case
well
multipl
timesepar
csf
sampl
collect
furthermor
although
four
diseas
case
histolog
confirm
inflammatori
brain
diseas
seven
case
presumpt
diagnos
muo
strict
inclus
criteria
use
antemortem
diagnosi
studi
howev
lack
histopatholog
definit
rule
diseas
process
lymphoma
therefor
possibl
presumpt
diagnos
muo
case
gme
nme
nle
addit
two
four
case
evalu
histopatholog
yield
definit
diagnosi
gme
nme
wherea
two
diagnos
meningoenceph
undetermin
subtyp
use
greater
number
case
histolog
confirm
could
strengthen
diagnost
certainti
case
allow
specif
investig
muo
base
histolog
type
also
sever
possibl
technic
reason
could
prevent
us
identifi
infecti
agent
underli
muo
first
might
lack
necessari
sensit
although
metagenom
sequenc
detect
pathogen
gener
less
sensit
target
method
pcr
sensit
pcr
typic
defin
absolut
unit
eg
genom
copi
quantit
pcr
reaction
sensit
metagenom
sequenc
limit
read
depth
rel
pathogen
concentr
exampl
metagenom
dataset
contain
million
uniqu
sequenc
pathogen
nucleic
acid
present
concentr
lower
part
per
million
host
nucleic
acid
molecul
unlik
detect
develop
use
method
deplet
mammalian
nucleic
acid
could
improv
sensit
studi
elimin
dog
sequenc
enrich
microorganism
nucleic
acid
analysi
bird
brain
sampl
high
low
wnv
copi
number
illustr
sensit
threshold
detect
wnv
sequenc
crow
brain
viral
rna
copi
per
microlit
rna
detect
wnv
robin
brain
genom
copi
per
microlit
rna
therefor
deduc
limit
detect
lie
somewher
valu
rang
larg
use
wnvposit
sampl
intermedi
copi
number
could
allow
us
narrow
empir
determin
limit
detect
addit
csf
inher
low
nucleic
acid
content
low
number
nucleat
cell
present
compar
tissu
therefor
dna
rna
extract
gener
low
yield
amplif
requir
librari
prepar
sampl
amplif
introduc
basecomposit
bia
increas
number
nonuniqu
read
contribut
reduc
sequenc
qualiti
read
depth
final
also
possibl
caus
muo
infecti
agent
diverg
known
pathogen
sequenc
unrecogniz
like
howev
eukaryot
bacteri
pathogen
typic
characterist
conserv
sequenc
easili
recogniz
eg
ribosom
rna
sequenc
virus
typic
recogn
viral
polymeras
sequenc
especi
compar
protein
level
summari
appli
best
avail
molecular
method
continu
search
muo
etiolog
find
candid
agent
sever
technic
biolog
reason
could
prevent
us
howev
thorough
approach
inclus
intern
posit
control
similar
neg
result
previou
studi
clinic
respons
immunosuppress
therapi
provid
support
hypothesi
muo
primari
autoimmun
diseas
